$HCC stock has now risen 13% today, according to our price data from Polygon. There has been approximately $37,780,625 of trading volume.
Here is what we see in our data on $HCC (you can track the company live on Quiver's $HCC stock page:$HCC Insider Trading Activity
$HCC insiders have traded $HCC stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HCC stock by insiders over the last 6 months:
- JACK K. RICHARDSON (CHIEF OPERATING OFFICER) purchased 1,815 shares for an estimated $84,270
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCC Hedge Fund Activity
We have seen 121 institutional investors add shares of $HCC stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TRUST ADVISORS LP added 1,143,380 shares (+1054.4%) to their portfolio in Q1 2025, for an estimated $54,562,093
- L1 CAPITAL PTY LTD added 718,309 shares (+inf%) to their portfolio in Q1 2025, for an estimated $34,277,705
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 660,000 shares (+412.5%) to their portfolio in Q1 2025, for an estimated $31,495,200
- VICTORY CAPITAL MANAGEMENT INC added 646,799 shares (+1918.4%) to their portfolio in Q1 2025, for an estimated $30,865,248
- SILVER POINT CAPITAL L.P. removed 645,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $30,779,400
- BALYASNY ASSET MANAGEMENT L.P. added 374,167 shares (+inf%) to their portfolio in Q1 2025, for an estimated $17,855,249
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 367,326 shares (+18.4%) to their portfolio in Q1 2025, for an estimated $17,528,796
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
You can track data on $HCC on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
